Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,999 | 1 | 69.2% |
| Travel and Lodging | $1,773 | 4 | 24.5% |
| Food and Beverage | $378.65 | 12 | 5.2% |
| Gift | $76.35 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | $6,263 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $827.50 | 7 | $0 (2019) |
| Chiesi USA, Inc. | $76.35 | 1 | $0 (2021) |
| Biogen, Inc. | $26.23 | 1 | $0 (2019) |
| Mindray DS USA, Inc. | $19.81 | 1 | $0 (2021) |
| Allergan Inc. | $13.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $96.16 | 2 | Chiesi USA, Inc. ($76.35) |
| 2019 | $7,080 | 14 | VERTEX PHARMACEUTICALS INCORPORATED ($6,226) |
| 2018 | $37.00 | 1 | Vertex Pharmaceuticals Incorporated ($37.00) |
| 2017 | $13.68 | 1 | Allergan Inc. ($13.68) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/13/2021 | Chiesi USA, Inc. | BRONCHITOL (Drug), PERTZYE | Gift | Cash or cash equivalent | $76.35 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/04/2021 | Mindray DS USA, Inc. | BENEVIEW SERIES (Device) | Food and Beverage | Cash or cash equivalent | $19.81 | General |
| Category: Monitoring Equipment | ||||||
| 12/04/2019 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $291.50 | General |
| 11/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $321.68 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $49.87 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $49.87 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.79 | General |
| 09/18/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $39.79 | General |
| 04/24/2019 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug), SYMDEKO, KALYDECO | Consulting Fee | Cash or cash equivalent | $4,999.00 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/08/2019 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug), SYMDEKO, KALYDECO | Travel and Lodging | In-kind items and services | $273.53 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/08/2019 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug), SYMDEKO, KALYDECO | Food and Beverage | In-kind items and services | $44.87 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/08/2019 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug), SYMDEKO, KALYDECO | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/08/2019 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug), SYMDEKO, KALYDECO | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/07/2019 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug), SYMDEKO, KALYDECO | Travel and Lodging | In-kind items and services | $885.87 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 10/18/2018 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $37.00 | General |
| 08/23/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROSCIENCE | ||||||
About Don Sanders
Don Sanders is a Pediatric Pulmonology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598874364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Don Sanders has received a total of $7,227 in payments from pharmaceutical and medical device companies, with $96.16 received in 2021. These payments were reported across 18 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($4,999).
Practice Information
- Specialty Pediatric Pulmonology
- Location Indianapolis, IN
- Active Since 08/29/2006
- Last Updated 01/04/2021
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1598874364
Products in Payments
- ORKAMBI (Drug) $6,226
- BRONCHITOL (Drug) $76.35
- TYSABRI (Biological) $26.23
- BENEVIEW SERIES (Device) $19.81
- VRAYLAR (Drug) $13.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Pulmonology Doctors in Indianapolis
Dr. Clement Ren, Md, MD
Pediatric Pulmonology — Payments: $36,618
John Stevens, Md, MD
Pediatric Pulmonology — Payments: $11,731
Gregory Montgomery, Md, MD
Pediatric Pulmonology — Payments: $2,119
Dr. Nadia Krupp, M.d, M.D
Pediatric Pulmonology — Payments: $1,464
James Chmiel, Md, MD
Pediatric Pulmonology — Payments: $1,202
Dr. Sandeep Puranik, M.d, M.D
Pediatric Pulmonology — Payments: $1,173